ARCHIVES

In Brief: CCIRC Recommends Central Oncology Group For Phasing Out; Rogers Backs Pay Raise

This article is from The Cancer Letter archive.

Vol. 02 No. 10 | March 5, 1976

Download PDF Visit The Full Archive

Related Articles

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

St. Jude Offers Two Fellowships

July 18, 1986

Novel Four Drug Combination Safe For Lung Cancer Therapy

November 28, 2008

European Commission Approves Subcutaneous Rituximab

March 28, 2014

1985 International Cancer Congress to Be In Budapest

September 24, 1982

FDA Approves Abbott’s HER-2 DNA Probe Kit.

January 25, 2002